Actively Recruiting
Dexamethasone in Tick-borne Encephalitis
Led by University Medical Centre Ljubljana · Updated on 2026-05-13
200
Participants Needed
1
Research Sites
334 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to investigate the efficacy of dexamethasone in patients with tick-borne encephalitis.
CONDITIONS
Official Title
Dexamethasone in Tick-borne Encephalitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Clinical signs and symptoms of meningoencephalitis or meningomyelitis
- Cerebrospinal pleocytosis
- Serological confirmation of tick-borne encephalitis virus infection
You will not qualify if you...
- Pregnancy
- Severe neurological impairment before tick-borne encephalitis
- Systemic corticosteroid treatment in the past 30 days
- Allergy to corticosteroids
- Immunosuppressive condition or therapy, including HIV with CD4 < 200/ml, organ or bone marrow transplant, chemotherapy, radiotherapy, primary immunodeficiency, or hematological malignancy
- Ventricular shunt
- Endoscopically documented peptic gastric ulcer in the past six months or gastrointestinal bleeding with hemoglobin drop ≥ 20 units
- Uncontrolled diabetes with hyperglycemia
- Antiviral therapy with rilpivirin
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Medical Centre Ljubljana
Ljubljana, Slovenia, 1000
Actively Recruiting
Research Team
D
Daša Stupica, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here